Request for Covid-19 Impact Assessment of this Report
The United States Thrombin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Thrombin market, reaching US$ million by the year 2028. As for the Europe Thrombin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Thrombin players cover Takeda, Bayer, CSL, and Grifols, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Thrombin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Diagnostics & Clinics
Academic and Research Institute
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Thrombin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Thrombin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Thrombin by Country/Region, 2017, 2022 & 2028
2.2 Thrombin Segment by Type
2.2.1 Powder Form
2.2.2 Solution Form
2.2.3 Pad Form
2.2.4 Spray Kits
2.2.5 Others
2.3 Thrombin Sales by Type
2.3.1 Global Thrombin Sales Market Share by Type (2017-2022)
2.3.2 Global Thrombin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Thrombin Sale Price by Type (2017-2022)
2.4 Thrombin Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics & Clinics
2.4.3 Academic and Research Institute
2.5 Thrombin Sales by Application
2.5.1 Global Thrombin Sale Market Share by Application (2017-2022)
2.5.2 Global Thrombin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Thrombin Sale Price by Application (2017-2022)
3 Global Thrombin by Company
3.1 Global Thrombin Breakdown Data by Company
3.1.1 Global Thrombin Annual Sales by Company (2020-2022)
3.1.2 Global Thrombin Sales Market Share by Company (2020-2022)
3.2 Global Thrombin Annual Revenue by Company (2020-2022)
3.2.1 Global Thrombin Revenue by Company (2020-2022)
3.2.2 Global Thrombin Revenue Market Share by Company (2020-2022)
3.3 Global Thrombin Sale Price by Company
3.4 Key Manufacturers Thrombin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thrombin Product Location Distribution
3.4.2 Players Thrombin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Thrombin by Geographic Region
4.1 World Historic Thrombin Market Size by Geographic Region (2017-2022)
4.1.1 Global Thrombin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Thrombin Annual Revenue by Geographic Region
4.2 World Historic Thrombin Market Size by Country/Region (2017-2022)
4.2.1 Global Thrombin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Thrombin Annual Revenue by Country/Region
4.3 Americas Thrombin Sales Growth
4.4 APAC Thrombin Sales Growth
4.5 Europe Thrombin Sales Growth
4.6 Middle East & Africa Thrombin Sales Growth
5 Americas
5.1 Americas Thrombin Sales by Country
5.1.1 Americas Thrombin Sales by Country (2017-2022)
5.1.2 Americas Thrombin Revenue by Country (2017-2022)
5.2 Americas Thrombin Sales by Type
5.3 Americas Thrombin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thrombin Sales by Region
6.1.1 APAC Thrombin Sales by Region (2017-2022)
6.1.2 APAC Thrombin Revenue by Region (2017-2022)
6.2 APAC Thrombin Sales by Type
6.3 APAC Thrombin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Thrombin by Country
7.1.1 Europe Thrombin Sales by Country (2017-2022)
7.1.2 Europe Thrombin Revenue by Country (2017-2022)
7.2 Europe Thrombin Sales by Type
7.3 Europe Thrombin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Thrombin by Country
8.1.1 Middle East & Africa Thrombin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Thrombin Revenue by Country (2017-2022)
8.2 Middle East & Africa Thrombin Sales by Type
8.3 Middle East & Africa Thrombin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thrombin
10.3 Manufacturing Process Analysis of Thrombin
10.4 Industry Chain Structure of Thrombin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thrombin Distributors
11.3 Thrombin Customer
12 World Forecast Review for Thrombin by Geographic Region
12.1 Global Thrombin Market Size Forecast by Region
12.1.1 Global Thrombin Forecast by Region (2023-2028)
12.1.2 Global Thrombin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Thrombin Forecast by Type
12.7 Global Thrombin Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Thrombin Product Offered
13.1.3 Takeda Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Thrombin Product Offered
13.2.3 Bayer Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Thrombin Product Offered
13.3.3 CSL Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Thrombin Product Offered
13.4.3 Grifols Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Thrombin Product Offered
13.5.3 GE Healthcare Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Hualan Biological
13.6.1 Hualan Biological Company Information
13.6.2 Hualan Biological Thrombin Product Offered
13.6.3 Hualan Biological Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hualan Biological Main Business Overview
13.6.5 Hualan Biological Latest Developments
13.7 Haematologic Technologies Inc.
13.7.1 Haematologic Technologies Inc. Company Information
13.7.2 Haematologic Technologies Inc. Thrombin Product Offered
13.7.3 Haematologic Technologies Inc. Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Haematologic Technologies Inc. Main Business Overview
13.7.5 Haematologic Technologies Inc. Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Thrombin Product Offered
13.8.3 Pfizer Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Octapharma
13.9.1 Octapharma Company Information
13.9.2 Octapharma Thrombin Product Offered
13.9.3 Octapharma Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Octapharma Main Business Overview
13.9.5 Octapharma Latest Developments
13.10 Omrix Biopharmaceuticals Ltd.
13.10.1 Omrix Biopharmaceuticals Ltd. Company Information
13.10.2 Omrix Biopharmaceuticals Ltd. Thrombin Product Offered
13.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Omrix Biopharmaceuticals Ltd. Main Business Overview
13.10.5 Omrix Biopharmaceuticals Ltd. Latest Developments
13.11 Shanghai RAAS
13.11.1 Shanghai RAAS Company Information
13.11.2 Shanghai RAAS Thrombin Product Offered
13.11.3 Shanghai RAAS Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shanghai RAAS Main Business Overview
13.11.5 Shanghai RAAS Latest Developments
14 Research Findings and Conclusion
Table 1. Thrombin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Thrombin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Powder Form
Table 4. Major Players of Solution Form
Table 5. Major Players of Pad Form
Table 6. Major Players of Spray Kits
Table 7. Major Players of Others
Table 8. Global Thrombin Sales by Type (2017-2022) & (MT)
Table 9. Global Thrombin Sales Market Share by Type (2017-2022)
Table 10. Global Thrombin Revenue by Type (2017-2022) & ($ million)
Table 11. Global Thrombin Revenue Market Share by Type (2017-2022)
Table 12. Global Thrombin Sale Price by Type (2017-2022) & (USD/Kg)
Table 13. Global Thrombin Sales by Application (2017-2022) & (MT)
Table 14. Global Thrombin Sales Market Share by Application (2017-2022)
Table 15. Global Thrombin Revenue by Application (2017-2022)
Table 16. Global Thrombin Revenue Market Share by Application (2017-2022)
Table 17. Global Thrombin Sale Price by Application (2017-2022) & (USD/Kg)
Table 18. Global Thrombin Sales by Company (2020-2022) & (MT)
Table 19. Global Thrombin Sales Market Share by Company (2020-2022)
Table 20. Global Thrombin Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Thrombin Revenue Market Share by Company (2020-2022)
Table 22. Global Thrombin Sale Price by Company (2020-2022) & (USD/Kg)
Table 23. Key Manufacturers Thrombin Producing Area Distribution and Sales Area
Table 24. Players Thrombin Products Offered
Table 25. Thrombin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Thrombin Sales by Geographic Region (2017-2022) & (MT)
Table 29. Global Thrombin Sales Market Share Geographic Region (2017-2022)
Table 30. Global Thrombin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Thrombin Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Thrombin Sales by Country/Region (2017-2022) & (MT)
Table 33. Global Thrombin Sales Market Share by Country/Region (2017-2022)
Table 34. Global Thrombin Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Thrombin Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Thrombin Sales by Country (2017-2022) & (MT)
Table 37. Americas Thrombin Sales Market Share by Country (2017-2022)
Table 38. Americas Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Thrombin Revenue Market Share by Country (2017-2022)
Table 40. Americas Thrombin Sales by Type (2017-2022) & (MT)
Table 41. Americas Thrombin Sales Market Share by Type (2017-2022)
Table 42. Americas Thrombin Sales by Application (2017-2022) & (MT)
Table 43. Americas Thrombin Sales Market Share by Application (2017-2022)
Table 44. APAC Thrombin Sales by Region (2017-2022) & (MT)
Table 45. APAC Thrombin Sales Market Share by Region (2017-2022)
Table 46. APAC Thrombin Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Thrombin Revenue Market Share by Region (2017-2022)
Table 48. APAC Thrombin Sales by Type (2017-2022) & (MT)
Table 49. APAC Thrombin Sales Market Share by Type (2017-2022)
Table 50. APAC Thrombin Sales by Application (2017-2022) & (MT)
Table 51. APAC Thrombin Sales Market Share by Application (2017-2022)
Table 52. Europe Thrombin Sales by Country (2017-2022) & (MT)
Table 53. Europe Thrombin Sales Market Share by Country (2017-2022)
Table 54. Europe Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Thrombin Revenue Market Share by Country (2017-2022)
Table 56. Europe Thrombin Sales by Type (2017-2022) & (MT)
Table 57. Europe Thrombin Sales Market Share by Type (2017-2022)
Table 58. Europe Thrombin Sales by Application (2017-2022) & (MT)
Table 59. Europe Thrombin Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Thrombin Sales by Country (2017-2022) & (MT)
Table 61. Middle East & Africa Thrombin Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Thrombin Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Thrombin Sales by Type (2017-2022) & (MT)
Table 65. Middle East & Africa Thrombin Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Thrombin Sales by Application (2017-2022) & (MT)
Table 67. Middle East & Africa Thrombin Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Thrombin
Table 69. Key Market Challenges & Risks of Thrombin
Table 70. Key Industry Trends of Thrombin
Table 71. Thrombin Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Thrombin Distributors List
Table 74. Thrombin Customer List
Table 75. Global Thrombin Sales Forecast by Region (2023-2028) & (MT)
Table 76. Global Thrombin Sales Market Forecast by Region
Table 77. Global Thrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Thrombin Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Thrombin Sales Forecast by Country (2023-2028) & (MT)
Table 80. Americas Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Thrombin Sales Forecast by Region (2023-2028) & (MT)
Table 82. APAC Thrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Thrombin Sales Forecast by Country (2023-2028) & (MT)
Table 84. Europe Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Thrombin Sales Forecast by Country (2023-2028) & (MT)
Table 86. Middle East & Africa Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Thrombin Sales Forecast by Type (2023-2028) & (MT)
Table 88. Global Thrombin Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Thrombin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Thrombin Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Thrombin Sales Forecast by Application (2023-2028) & (MT)
Table 92. Global Thrombin Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Thrombin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Thrombin Revenue Market Share Forecast by Application (2023-2028)
Table 95. Takeda Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 96. Takeda Thrombin Product Offered
Table 97. Takeda Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 98. Takeda Main Business
Table 99. Takeda Latest Developments
Table 100. Bayer Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 101. Bayer Thrombin Product Offered
Table 102. Bayer Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 103. Bayer Main Business
Table 104. Bayer Latest Developments
Table 105. CSL Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Thrombin Product Offered
Table 107. CSL Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. Grifols Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 111. Grifols Thrombin Product Offered
Table 112. Grifols Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 113. Grifols Main Business
Table 114. Grifols Latest Developments
Table 115. GE Healthcare Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 116. GE Healthcare Thrombin Product Offered
Table 117. GE Healthcare Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 118. GE Healthcare Main Business
Table 119. GE Healthcare Latest Developments
Table 120. Hualan Biological Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 121. Hualan Biological Thrombin Product Offered
Table 122. Hualan Biological Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 123. Hualan Biological Main Business
Table 124. Hualan Biological Latest Developments
Table 125. Haematologic Technologies Inc. Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 126. Haematologic Technologies Inc. Thrombin Product Offered
Table 127. Haematologic Technologies Inc. Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 128. Haematologic Technologies Inc. Main Business
Table 129. Haematologic Technologies Inc. Latest Developments
Table 130. Pfizer Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 131. Pfizer Thrombin Product Offered
Table 132. Pfizer Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 133. Pfizer Main Business
Table 134. Pfizer Latest Developments
Table 135. Octapharma Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 136. Octapharma Thrombin Product Offered
Table 137. Octapharma Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 138. Octapharma Main Business
Table 139. Octapharma Latest Developments
Table 140. Omrix Biopharmaceuticals Ltd. Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 141. Omrix Biopharmaceuticals Ltd. Thrombin Product Offered
Table 142. Omrix Biopharmaceuticals Ltd. Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 143. Omrix Biopharmaceuticals Ltd. Main Business
Table 144. Omrix Biopharmaceuticals Ltd. Latest Developments
Table 145. Shanghai RAAS Basic Information, Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 146. Shanghai RAAS Thrombin Product Offered
Table 147. Shanghai RAAS Thrombin Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 148. Shanghai RAAS Main Business
Table 149. Shanghai RAAS Latest Developments
List of Figures
Figure 1. Picture of Thrombin
Figure 2. Thrombin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Thrombin Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Thrombin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Thrombin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Powder Form
Figure 10. Product Picture of Solution Form
Figure 11. Product Picture of Pad Form
Figure 12. Product Picture of Spray Kits
Figure 13. Product Picture of Others
Figure 14. Global Thrombin Sales Market Share by Type in 2021
Figure 15. Global Thrombin Revenue Market Share by Type (2017-2022)
Figure 16. Thrombin Consumed in Hospitals
Figure 17. Global Thrombin Market: Hospitals (2017-2022) & (MT)
Figure 18. Thrombin Consumed in Diagnostics & Clinics
Figure 19. Global Thrombin Market: Diagnostics & Clinics (2017-2022) & (MT)
Figure 20. Thrombin Consumed in Academic and Research Institute
Figure 21. Global Thrombin Market: Academic and Research Institute (2017-2022) & (MT)
Figure 22. Global Thrombin Sales Market Share by Application (2017-2022)
Figure 23. Global Thrombin Revenue Market Share by Application in 2021
Figure 24. Thrombin Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Thrombin Revenue Market Share by Company in 2021
Figure 26. Global Thrombin Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Thrombin Revenue Market Share by Geographic Region in 2021
Figure 28. Global Thrombin Sales Market Share by Region (2017-2022)
Figure 29. Global Thrombin Revenue Market Share by Country/Region in 2021
Figure 30. Americas Thrombin Sales 2017-2022 (MT)
Figure 31. Americas Thrombin Revenue 2017-2022 ($ Millions)
Figure 32. APAC Thrombin Sales 2017-2022 (MT)
Figure 33. APAC Thrombin Revenue 2017-2022 ($ Millions)
Figure 34. Europe Thrombin Sales 2017-2022 (MT)
Figure 35. Europe Thrombin Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Thrombin Sales 2017-2022 (MT)
Figure 37. Middle East & Africa Thrombin Revenue 2017-2022 ($ Millions)
Figure 38. Americas Thrombin Sales Market Share by Country in 2021
Figure 39. Americas Thrombin Revenue Market Share by Country in 2021
Figure 40. United States Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Thrombin Sales Market Share by Region in 2021
Figure 45. APAC Thrombin Revenue Market Share by Regions in 2021
Figure 46. China Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Thrombin Sales Market Share by Country in 2021
Figure 53. Europe Thrombin Revenue Market Share by Country in 2021
Figure 54. Germany Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Thrombin Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Thrombin Revenue Market Share by Country in 2021
Figure 61. Egypt Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Thrombin in 2021
Figure 67. Manufacturing Process Analysis of Thrombin
Figure 68. Industry Chain Structure of Thrombin
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...